Investment House LLC trimmed its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 0.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 84,508 shares of the financial services provider’s stock after selling 537 shares during the period. iShares Nasdaq Biotechnology ETF accounts for 0.9% of Investment House LLC’s holdings, making the stock its 29th biggest position. Investment House LLC owned about 0.12% of iShares Nasdaq Biotechnology ETF worth $12,802,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. AlphaMark Advisors LLC acquired a new stake in iShares Nasdaq Biotechnology ETF during the third quarter worth about $27,000. Bainco International Investors acquired a new stake in shares of iShares Nasdaq Biotechnology ETF during the fourth quarter valued at about $27,000. Stumpf Capital Management LLC acquired a new stake in shares of iShares Nasdaq Biotechnology ETF during the third quarter valued at about $34,000. JFS Wealth Advisors LLC increased its position in shares of iShares Nasdaq Biotechnology ETF by 488.9% during the third quarter. JFS Wealth Advisors LLC now owns 265 shares of the financial services provider’s stock valued at $36,000 after acquiring an additional 220 shares during the last quarter. Finally, Clear Harbor Asset Management LLC acquired a new stake in shares of iShares Nasdaq Biotechnology ETF during the third quarter valued at about $45,000. 76.00% of the stock is currently owned by institutional investors and hedge funds.

Separately, ValuEngine cut shares of iShares Nasdaq Biotechnology ETF from a “hold” rating to a “sell” rating in a research report on Monday, November 16th.

Shares of IBB traded down $0.33 during trading on Wednesday, reaching $158.03. 1,790,105 shares of the company traded hands, compared to its average volume of 3,407,276. iShares Nasdaq Biotechnology ETF has a twelve month low of $92.15 and a twelve month high of $159.62. The stock has a 50-day simple moving average of $154.62 and a 200-day simple moving average of $143.56.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Featured Article: Net Asset Value

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.